Publication date: Dec 12, 2019 Radiation retinopathy following plaque radiotherapy for uveal melanoma can lead to vision loss that might be avoided with prophylactic anti-vascular endothelial growth factor treatment. To ... Read more

Publication date: Dec 04, 2019 Pembrolizumab is approved for the treatment of advanced cancer in adults; however, no information is available on safety and efficacy in paediatric patients. We aimed ... Read more

Publication date: Dec 05, 2019 Increasing numbers of patients are now offered immunotherapy as part of their cancer treatment. These treatments, while often very effective, have a wide range of ... Read more

Publication date: Dec 04, 2019 With the introduction of novel immune therapeutics for the treatment of disseminated malignancies, we sought to evaluate whether deliberate sequencing of immunotherapy before/after conventional cytotoxic ... Read more

Publication date: Dec 05, 2019 PD-1 inhibitors are routinely used for the treatment of advanced melanoma. This study sought to determine whether PD-L1 expression on circulating tumor cells (CTCs) can ... Read more

Publication date: Dec 02, 2019 Immune checkpoint inhibitors (ICPis) have revolutionised the treatment of melanoma by significantly increasing survival rates and disease control. However, ICPis can have specific immune-related adverse ... Read more

Publication date: Nov 18, 2019 We report a case in which a renal transplant recipient with metastatic melanoma had an excellent response to treatment with second line programmed cell death ... Read more

Publication date: Oct 04, 2019 Nivolumab plus ipilimumab combined therapy is one of the promising drugs that enhance the anti- immune response in patients with advanced melanoma. Therefore, to increase ... Read more